Yamagata K - Search Results

1

Renal Hemodynamic and Functional Changes in ADPKD Patients.

Ishii R, Kai H, Nakajima K, Harada T, Akiyama T, Okada E, Tsunoda R, Usui T, Mase K, Morito N, Saito C, Usui J, Yamagata K. Ishii R, et al. Among authors: yamagata k. Kidney360. 2024 Mar 21. doi: 10.34067/KID.0000000000000412. Online ahead of print. Kidney360. 2024. PMID: 38511865 Free article.

2

[Recurrent retroperitoneal fibrosis associated with hyperglobulinemia].

Ohteki T, Tomida C, Goto M, Usui J, Muro K, Yamagata K, Koyama A. Ohteki T, et al. Among authors: yamagata k. Nihon Naika Gakkai Zasshi. 2000 Oct 10;89(10):2183-5. doi: 10.2169/naika.89.2183. Nihon Naika Gakkai Zasshi. 2000. PMID: 11215135 Japanese. No abstract available.

3

Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features.

Usui J, Yamagata K, Kai H, Outeki T, Yamamoto S, Muro K, Hirayama A, Yoh K, Tomida C, Hirayama K, Suzuki S, Kobayashi M, Nagata M, Koyama A. Usui J, et al. Among authors: yamagata k. Intern Med. 2001 Aug;40(8):697-702. doi: 10.2169/internalmedicine.40.697. Intern Med. 2001. PMID: 11518105 Free article.

4

Predominance of type-2 immune response in idiopathic membranous nephropathy. Cytoplasmic cytokine analysis.

Hirayama K, Ebihara I, Yamamoto S, Kai H, Muro K, Yamagata K, Kobayashi M, Koyama A. Hirayama K, et al. Among authors: yamagata k. Nephron. 2002 Jun;91(2):255-61. doi: 10.1159/000058401. Nephron. 2002. PMID: 12053062

5

Mitochondrial DNA mutations in focal segmental glomerulosclerosis lesions.

Yamagata K, Muro K, Usui J, Hagiwara M, Kai H, Arakawa Y, Shimizu Y, Tomida C, Hirayama K, Kobayashi M, Koyama A. Yamagata K, et al. J Am Soc Nephrol. 2002 Jul;13(7):1816-23. doi: 10.1097/01.asn.0000019772.17954.f8. J Am Soc Nephrol. 2002. PMID: 12089377

6

Glomerular crescents predominantly express cadherin-catenin complex in pauci-immune-type crescentic glomerulonephritis.

Usui J, Kanemoto K, Tomari S, Shu Y, Yoh K, Mase K, Hirayama A, Hirayama K, Yamagata K, Nagase S, Kobayashi M, Nitta K, Horita S, Koyama A, Nagata M. Usui J, et al. Among authors: yamagata k. Histopathology. 2003 Aug;43(2):173-9. doi: 10.1046/j.1365-2559.2003.01660.x. Histopathology. 2003. PMID: 12877733

7

Age distribution and yearly changes in the incidence of ESRD in Japan.

Yamagata K, Takahashi H, Suzuki S, Mase K, Hagiwara M, Shimizu Y, Hirayama K, Kobayashi M, Narita M, Koyama A. Yamagata K, et al. Am J Kidney Dis. 2004 Mar;43(3):433-43. doi: 10.1053/j.ajkd.2003.11.005. Am J Kidney Dis. 2004. PMID: 14981601

8

Staphylococcus aureus cell envelope antigen is a new candidate for the induction of IgA nephropathy.

Koyama A, Sharmin S, Sakurai H, Shimizu Y, Hirayama K, Usui J, Nagata M, Yoh K, Yamagata K, Muro K, Kobayashi M, Ohtani K, Shimizu T, Shimizu T. Koyama A, et al. Among authors: yamagata k. Kidney Int. 2004 Jul;66(1):121-32. doi: 10.1111/j.1523-1755.2004.00714.x. Kidney Int. 2004. PMID: 15200419 Free article.

9

Treatment with the purine synthesis inhibitor mizoribine for ANCA-associated renal vasculitis.

Hirayama K, Kobayashi M, Hashimoto Y, Usui J, Shimizu Y, Hirayama A, Yoh K, Yamagata K, Nagase S, Nagata M, Koyama A. Hirayama K, et al. Among authors: yamagata k. Am J Kidney Dis. 2004 Jul;44(1):57-63. doi: 10.1053/j.ajkd.2004.03.030. Am J Kidney Dis. 2004. PMID: 15211438 Clinical Trial.

10

Apheresis for MPO-ANCA-associated RPGN-indications and efficacy: lessons learned from Japan nationwide survey of RPGN.

Yamagata K, Hirayama K, Mase K, Yamaguchi N, Kobayashi M, Takahashi H, Koyama A. Yamagata K, et al. J Clin Apher. 2005 Dec;20(4):244-51. doi: 10.1002/jca.20035. J Clin Apher. 2005. PMID: 15880406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,342 results

Search Page